Motion to add a Gillette defence: Court refuses when pleadings would conflict
The Federal Court recently dismissed a motion to amend pleadings in a patent dispute between Janssen Inc. and Pharmascience Inc. Associate Judge...Read More
Court finds eculizumab patent neither anticipated nor obvious
In the first PMNOC decision of the year, Justice Furlanetto upheld the validity of claims 1 and 2 of Alexion’s patent no....Read More